Soluble epoxide hydrolase: a potential target for metabolic diseases: 可溶性表氧化物酶: 代谢性疾病的潜在治疗靶点

J He, C Wang, Y Zhu, D Ai - Journal of diabetes, 2016 - Wiley Online Library
摘要环氧‐二十碳三烯酸(Epoxyeicosatrienoic acids, EET) 是花生四烯酸的重要代谢产物. EET
在包括动脉粥样硬化, 高血压, 心脏纤维化, 糖尿病, 非酒精性脂肪肝以及肾脏疾病在内的诸多 …

Postprandial effect to decrease soluble epoxide hydrolase activity: Roles of insulin and gut microbiota

J Yang, YT Oh, D Wan, RM Watanabe… - The Journal of nutritional …, 2017 - Elsevier
Epoxides of free fatty acids (FFAs), especially epoxyeicosatrienoic acids (EETs), are lipid
mediators with beneficial effects in metabolic and cardiovascular (CV) health. FFA epoxides …

Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides

C López-Vicario, J Alcaraz-Quiles… - Proceedings of the …, 2015 - National Acad Sciences
Soluble epoxide hydrolase (sEH) is an emerging therapeutic target in a number of diseases
that have inflammation as a common underlying cause. sEH limits tissue levels of …

EETs/sEH in diabetes and obesity-induced cardiovascular diseases

H Huang, J Weng, MH Wang - Prostaglandins & other lipid mediators, 2016 - Elsevier
Despite the optimization of blood glucose control and the therapeutic management of risk
factors, obesity-and diabetes-induced cardiovascular diseases are still major health …

Soluble epoxide hydrolase inhibitors and cardiovascular diseases

ZH Wang, BB Davis, DQ Jiang… - Current Vascular …, 2013 - ingentaconnect.com
Background: Epoxyeicosatrienoic acids (EETs) have been shown to play a role in
cardiovascular protection by reducing ischemia reperfusion injury, producing anti …

Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health

C Morisseau, BD Hammock - Annual review of pharmacology …, 2013 - annualreviews.org
The presence of epoxyeicosatrienoic acids (EETs) in tissues and their metabolism by
soluble epoxide hydrolase (sEH) to 1, 2-diols were first reported 30 years ago. However …

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases

JD Imig, BD Hammock - Nature reviews Drug discovery, 2009 - nature.com
The cardiovascular effects of epoxyeicosatrienoic acids (EETs) include vasodilation,
antimigratory actions on vascular smooth muscle cells and anti-inflammatory actions. These …

GSK2256294 decreases sEH (soluble epoxide hydrolase) activity in plasma, muscle, and adipose and reduces F2-isoprostanes but does not alter insulin sensitivity in …

JM Luther, J Ray, D Wei, JR Koethe, L Hannah… - …, 2021 - Am Heart Assoc
Epoxyeicosatrienoic acids (EETs) reduce blood pressure by acting in the vasculature and
kidney, and interventions to increase circulating EETs improve insulin sensitivity and prevent …

[HTML][HTML] The role of cytochrome P450 epoxygenases, soluble epoxide hydrolase, and epoxyeicosatrienoic acids in metabolic diseases

X Xu, R Li, G Chen, SL Hoopes, DC Zeldin… - Advances in nutrition, 2016 - Elsevier
Metabolic diseases are associated with an increased risk of developing cardiovascular
disease. The features comprising metabolic diseases include obesity, insulin resistance …

[HTML][HTML] Inside epoxyeicosatrienoic acids and cardiovascular disease

S Tacconelli, P Patrignani - Frontiers in pharmacology, 2014 - frontiersin.org
Epoxyeicosatrienoic acids (EETs) generated from arachidonic acid through cytochrome
P450 (CYP) epoxygenases have many biological functions. Importantly, CYP epoxygenase …